Plain-English translation of NCT07072143 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
The PARTNER Study is an international research project that gathers medical information from children and young people diagnosed with very rare cancers. By collecting data about diagnoses, treatments, and outcomes across multiple hospitals in Europe, researchers aim to better understand these uncommon tumors and develop improved treatment approaches for future patients.
These cancers are so rare that very little is known about them — there haven't been enough patients studied together to understand what works best. By bringing together information from thousands of children across many countries, doctors hope to identify patterns that will lead to better care and improved outcomes.
You likely qualify if…
You likely don't qualify if…
As a participant, your doctors will share your medical records, test results, imaging scans, and treatment information with the study team — no extra hospital visits are required. Your information will be added to an international database that helps researchers understand these rare cancers better. The study will continue to follow your medical progress over time as part of normal care.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
Italy
Azienda Ospedaliera di Padova
Collaborators
St. Anna Children's Hospital, Vienna, Children's Hospital Zagreb
Enrollment target
~6,250 participants
Started
January 2025
Primary completion
January 2049
Age range
0 Years – 18 Years
Last updated on clinicaltrials.gov in July 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Gianni Bisogno, MD
Azienda Ospedale Università Padova - Italy
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.